The Food and Drug Administration last week approved a medical device made by Laguna Hills-based startup Glaukos Inc.
Glaukos’ iStent is used in combination with cataract surgery in order to reduce pressure inside the eyes of adults who have mild or moderate open-angle glaucoma and a catar-act.
The iStent is Glaukos’ first device approved in the U.S.; the device is already approved in Europe.
Glaukos has attracted some $126 million in venture capital funding since its establishment in 2001.
The company’s management team includes several veterans of other eye drug and device companies, including Irvine-based Allergan Inc. and Abbott Medical Optics, a Santa Ana unit of Abbott Laboratories in Abbott Park, Ill.